تاریخچه درآمد، سود و جریان نقد از صورتهای مالی رسمی.
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products.
نمودارهای تعاملی و صورتهای مالی کامل ← مدل ارزشگذاری (DCF) ←
| صورت سود و زیان | TTM → 2026-03-31 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 | 2016-06-30 | 2015-06-30 | 2014-06-30 | 2013-06-30 | 2012-06-30 | 2011-06-30 | 2010-06-30 | 2009-06-30 | 2008-06-30 | 2007-06-30 | 2006-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| مجموع درآمد | $250.5B | $222.6B | $226.8B | $205.0B | $181.3B | $162.5B | $152.9B | $145.5B | $136.8B | $130.0B | $121.5B | $102.5B | $91.1B | $101.1B | $107.6B | $102.6B | $98.5B | $96.0B | $87.4B | $86.9B | $79.7B |
| سود ناخالص | $9.2B | $8.2B | $7.4B | $6.9B | $6.5B | $6.8B | $6.9B | $6.8B | $7.2B | $6.5B | $6.5B | $5.7B | $5.2B | $4.9B | $4.5B | $4.2B | $3.8B | $5.5B | $5.6B | $5.2B | $5.3B |
| حاشیه سود ناخالص % | 3.7% | 3.7% | 3.3% | 3.4% | 3.6% | 4.2% | 4.5% | 4.7% | 5.2% | 5.0% | 5.4% | 5.6% | 5.7% | 4.9% | 4.2% | 4.0% | 3.8% | 5.8% | 6.5% | 6.0% | 6.6% |
| سود عملیاتی (EBIT) | $2.3B | $2.3B | $1.2B | $752M | ($607M) | $472M | ($4.1B) | $2.1B | $126M | $2.1B | $2.5B | $2.2B | $1.9B | $996M | $1.8B | $1.5B | $1.3B | $1.3B | $1.4B | $1.4B | $1.8B |
| حاشیه سود عملیاتی % | 0.9% | 1.0% | 0.5% | 0.4% | -0.3% | 0.3% | -2.7% | 1.4% | 0.1% | 1.6% | 2.0% | 2.1% | 2.1% | 1.0% | 1.7% | 1.5% | 1.3% | 1.3% | 1.6% | 1.6% | 2.3% |
| سود خالص | $1.6B | $1.6B | $852M | $330M | ($938M) | $611M | ($3.7B) | $1.4B | $256M | $1.3B | $1.4B | $1.2B | $1.2B | $334M | $1.1B | $959M | $642M | $1.2B | $1.3B | $1.9B | $1.0B |
| حاشیه سود خالص % | 0.6% | 0.7% | 0.4% | 0.2% | -0.5% | 0.4% | -2.4% | 0.9% | 0.2% | 1.0% | 1.2% | 1.2% | 1.3% | 0.3% | 1.0% | 0.9% | 0.7% | 1.2% | 1.5% | 2.2% | 1.3% |
| EBITDA | $3.0B | $3.1B | $2.0B | $1.4B | $55M | $1.3B | ($2.6B) | $3.0B | $1.1B | $2.8B | $3.1B | $2.6B | $2.4B | $1.4B | $2.1B | $1.9B | $1.6B | $1.6B | $1.7B | $1.8B | $2.2B |
| سود هر سهم (EPS) | $6.56 | $6.45 | $3.45 | $1.26 | $-3.36 | $2.08 | $-12.60 | $4.53 | $0.81 | $4.03 | $4.32 | $3.63 | $3.38 | $0.97 | $3.06 | $2.72 | $1.78 | $3.19 | $3.57 | $4.77 | $2.33 |
| سهام منتشرشده (میلیون) | 236M | 242M | 247M | 262M | 279M | 294M | 293M | 301M | 315M | 320M | 330M | 335M | 345M | 344M | 349M | 352M | 361M | 362M | 364M | 405M | 428M |
منبع: گزارشهای عمومی شرکت (SEC). پیش از اتکا به هر رقم، آن را در SEC EDGAR بررسی کنید.
ترازنامهها، جریانهای نقدی، دادههای فصلی و نسبتهای مالی کامل در نمایشگر تعاملی CAH در دسترس است. /companies/us/CAH
اطلاعات این وبسایت صرفاً برای اهداف آموزشی و اطلاعرسانی است و توصیه سرمایهگذاری نیست. هیچ هدف قیمتی یا توصیهای منتشر نمیشود.
About TickerBase · Data methodology & sources · Privacy · Terms